White Papers2020-10-30T19:34:10+00:00


Acacia Research: Undervalued Biotech Tentacles

In this research note, Formidable takes a deep dive into Acacia Research Corporation (NASDAQ: ACTG), which represents an investment opportunity in secondary private equity, as well as patent litigation (its historical bailiwick). See below for the company’s mission statement, pulled from its website.

June 23rd, 2021|

Gamma Squeeze. Who is Next?

Investors are seemingly always hunting for potential opportunities in the short squeeze space. However, what we have seen recently are short squeezes that are biblical in nature.

June 1st, 2021|


Let us know how we can help and a member of our team will help get you started.

  • This field is for validation purposes and should be left unchanged.